BRISTOL MYERS SQUIBB
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
- First Posted Date
- 2006-06-28
- Last Posted Date
- 2011-04-25
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 194
- Registration Number
- NCT00345748
- Locations
- 🇯🇵
Local Institution, Tochigi, Japan
Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer
- First Posted Date
- 2006-06-27
- Last Posted Date
- 2009-11-13
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 53
- Registration Number
- NCT00344552
- Locations
- 🇯🇵
Local Institution, Saitama, Japan
Study to Evaluate The Analgesic Efficacy and Safety of Intravenous Paracetamol in Subjects With Postoperative Pain After Total Hip Arthroplasty
- First Posted Date
- 2006-06-26
- Last Posted Date
- 2015-11-04
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 86
- Registration Number
- NCT00344045
- Locations
- 🇪🇸
Local Institution, Vizcaya, Spain
Study of Dasatinib (BMS-354825) in Patients With Solid Tumors
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2010-12-15
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 16
- Registration Number
- NCT00339144
- Locations
- 🇯🇵
Local Institution, Koto-Ku, Tokyo, Japan
Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan
- First Posted Date
- 2006-06-16
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 48
- Registration Number
- NCT00337454
- Locations
- 🇯🇵
Local Institution, Tokyo, Japan
A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer
- First Posted Date
- 2006-06-16
- Last Posted Date
- 2010-02-04
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 50
- Registration Number
- NCT00337532
- Locations
- 🇰🇷
Local Institution, Seoul, Korea, Republic of
🇰🇷Local Insitution, Seoul, Korea, Republic of
Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression
- Conditions
- Human Immunodeficiency Virus (HIV) Infections
- Interventions
- First Posted Date
- 2006-06-16
- Last Posted Date
- 2010-07-19
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 61
- Registration Number
- NCT00337467
- Locations
- 🇪🇸
Local Institution, Malaga, Spain
A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer
- Conditions
- Cancer
- First Posted Date
- 2006-06-02
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 36
- Registration Number
- NCT00332748
- Locations
- 🇳🇱
Local Institution, Amsterdam, Netherlands
A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2011-01-25
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 89
- Registration Number
- NCT00329004
- Locations
- 🇪🇸
Local Institution, Barcelona, Spain
🇺🇸Indiana University Med Center, Indianapolis, Indiana, United States
🇺🇸The University Of Texas Md Anderson Cancer Center, Houston, Texas, United States
A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Drug: AR Antagonist (BMS-641988)
- First Posted Date
- 2006-05-17
- Last Posted Date
- 2011-01-25
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 54
- Registration Number
- NCT00326586
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸University Of Wisconsin Hospital And Clinics Laboratory, Madison, Wisconsin, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore, Maryland, United States